Matthew P. Fox, DSc

Professor, Epidemiology
Matthew Fox
(617) 414-1270mfox@bu.edu
Crosstown Center – CT372
View full profile at BUMC

Biography

Matthew Fox, DSc, MPH, is a Professor in the Departments of Epidemiology and Global Health at Boston University. Dr. Fox joined Boston University in 2001. His research interests include treatment outcomes in HIV-treatment programs, infectious disease epidemiology (with specific interests in HIV and pneumonia), and epidemiologic methods. Dr. Fox works on ways to improve retention in HIV-care programs in South Africa from the time of testing HIV-positive through long-term treatment. As part of this work, he is involved in analyses to assess the impact of changes in South Africa’s National Treatment Guidelines for HIV. Dr. Fox also does research on quantitative bias analysis and co-authored a book on these methods, Applying Quantitative Bias Analysis to Epidemiologic Data. He currently teaches a third-level epidemiologic methods class, Advanced Epidemiology as well as two other doctoral level epidemiologic methods courses. Dr. Fox is a graduate of the Boston University School of Public Health with a master’s degree in epidemiology and biostatistics and a doctorate in epidemiology.

Other Positions

  • Professor, Global Health, Boston University School of Public Health
  • Center Faculty Member, Center for Global Health & Development , Boston University School of Public Health

Education

  • Bates College, BA
  • Boston University School of Public Health, MPH
  • Boston University School of Public Health, DSc

Classes Taught

  • SPHEP854
  • SPHEP861
  • SPHEP862

Publications

  • Published on 1/17/2017

    Maskew M, Bor J, Hendrickson C, MacLeod W, Bärnighausen T, Pillay D, Sanne I, Carmona S, Stevens W, Fox MP. Imputing HIV treatment start dates from routine laboratory data in South Africa: a validation study. BMC Health Serv Res. 2017 Jan 17; 17(1):41. PMID: 28095905.

    Read at: PubMed
  • Published on 1/15/2017

    Heaton B, Gordon NB, Garcia RI, Rosenberg L, Rich S, Fox MP, Cozier YC. A Clinical Validation of Self-Reported Periodontitis Among Participants in the Black Women's Health Study. J Periodontol. 2017 Jan 15; 1-13. PMID: 28088874.

    Read at: PubMed
  • Published on 1/14/2017

    Brennan AT, Bonawitz R, Gill CJ, Thea DM, Long L, Fox MP. Prioritizing health outcomes of HIV-exposed, uninfected children in low and middle-income countries: response to Powis et al. AIDS. 2017 Jan 14; 31(2):317. PMID: 28002088.

    Read at: PubMed
  • Published on 1/2/2017

    Brennan AT, Davies MA, Bor J, Wandeler G, Stinson K, Wood R, Prozesky H, Tanser F, Fatti G, Boulle A, Sikazwe I, Wools-Kaloustian K, Yiannoutsos C, Leroy V, de Rekeneire N, Fox MP. Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa? AIDS. 2017 Jan 02; 31(1):147-157. PMID: 27930403.

    Read at: PubMed
  • Published on 1/2/2017

    Brennan AT, Davies MA, Bor J, Wandeler G, Stinson K, Wood R, Prozesky H, Tanser F, Fatti G, Boulle A, Sikazwe I, Wool-Kaloustian K, Yuannoutsos C, Leroy V, de Rekeneire N, Fox MP. Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa? AIDS. 2017 Jan 02; 31(1):147-157. PMID: 27776039.

    Read at: PubMed
  • Published on 12/12/2016

    Long LC, Rosen SB, Brennan A, Moyo F, Sauls C, Evans D, Modi SL, Sanne I, Fox MP. Treatment Outcomes and Costs of Providing Antiretroviral Therapy at a Primary Health Clinic versus a Hospital-Based HIV Clinic in South Africa. PLoS One. 2016; 11(12):e0168118. PMID: 27942005.

    Read at: PubMed
  • Published on 11/11/2016

    Brennan AT, Bor J, Davies MA, Conradie F, Maskew M, Long L, Sanne I, Fox MP. Tenofovir stock shortages have limited impact on clinic- and patient-level HIV treatment outcomes in public sector clinics in South Africa. Trop Med Int Health. 2016 Nov 11. PMID: 27862762.

    Read at: PubMed
  • Published on 11/1/2016

    Evans D, Berhanu R, Moyo F, Nguweneza A, Long L, Fox MP. Can Short-Term Use of Electronic Patient Adherence Monitoring Devices Improve Adherence in Patients Failing Second-Line Antiretroviral Therapy? Evidence from a Pilot Study in Johannesburg, South Africa. AIDS Behav. 2016 Nov; 20(11):2717-2728. PMID: 27146828.

    Read at: PubMed
  • Published on 10/31/2016

    Shearer K, Evans D, Moyo F, Rohr JK, Berhanu R, Van Den Berg L, Long L, Sanne I, Fox MP. Treatment outcomes of over 1000 patients on second-line, protease inhibitor-based antiretroviral therapy from four public-sector HIV treatment facilities across Johannesburg, South Africa. Trop Med Int Health. 2016 Oct 31. PMID: 27797443.

    Read at: PubMed
  • Published on 10/27/2016

    Maskew M, Fox MP, Evans D, Govindasamy D, Jamieson L, Malete G, Mongwenyana C, Technau K. Insights into Adherence among a Cohort of Adolescents Aged 12-20 Years in South Africa: Reported Barriers to Antiretroviral Treatment. AIDS Res Treat. 2016; 2016:4161738. PMID: 27867661.

    Read at: PubMed

View 132 more publications:View full profile at BUMC

News & In the Media